VAXX Stock Financial Analysis - Vaxxinity, Inc. (OTCPK) Stock

Quality, Value, Momentum Scores

This card shows the Quality, Value, and Momentum scores for the company

Quality

The QualityScore is a proprietary scoring model that identifies high quality companies, based on cash generating efficiencies.

Value

Proprietary scoring model that ranks companies based on their relative valuation. Scores range from 0 to 100, with 100 being the most undervalued.

Momentum

Proprietary scoring model that ranks companies on their six-month momentum.

Fund Sentiment

The Fund Sentiment (fka Ownership) score is a proprietary quantitative model that ranks companies based on levels of ownership accumulation.

QVM

The QVM Score is a proprietary scoring model that combines Quality, Value, and Momentum into a single metric that ranks companies from 0 to 100.

Income Statement: Revenue, Operating Income, Net Income

The operating income for Vaxxinity, Inc. as of December 31, 2023 is -58.28 MM.
The net income for Vaxxinity, Inc. as of December 31, 2023 is -56.93 MM.

Period End (TTM)	Revenue (MM)	Operating Income (MM)	Net Income (MM)
2023-12-31		-58.28	-56.93
2023-09-30		-67.46	-66.00
2023-06-30		-73.78	-72.11
2023-03-31		-76.62	-75.38
2022-12-31		-75.98	-75.22
2022-09-30	-0.00	-102.91	-102.62
2022-06-30	0.05	-113.41	-113.76
2022-03-31	0.05	-122.98	-123.42
2021-12-31	0.07	-125.08	-137.18
2021-09-30	0.07	-88.55	-102.04
2021-06-30	0.13	-70.97	-88.12
2021-03-31	0.57	-49.99	-68.27
2020-12-31	0.56	-32.28	-39.96

Income Statement: EPS

The earnings per share basic for Vaxxinity, Inc. as of December 31, 2023 is -0.45.

Period End (TTM)	Earnings Per Share Basic	Earnings Per Share Diluted
2023-12-31	-0.45
2023-09-30	-0.52	-0.52
2023-06-30	-0.57	-0.57
2023-03-31	-0.60	-0.60
2022-12-31	-0.60
2022-09-30	-0.86	-0.86
2022-06-30	-1.08	-1.08
2022-03-31	-1.36	-1.36
2021-12-31	-1.79
2021-09-30	-1.39	-1.39
2021-06-30	-1.17	-1.17
2021-03-31	-0.92	-0.92
2020-12-31	-0.61

Cash Flow: Operations, Investing, Financing

The cash from operating activities for Vaxxinity, Inc. as of December 31, 2023 is -57.24 MM.
The cash from investing activities for Vaxxinity, Inc. as of December 31, 2023 is 28.84 MM.
The cash from financing activities for Vaxxinity, Inc. as of December 31, 2023 is -1.14 MM.

Period End (TTM)	Cash From Operating Activities (MM)	Cash From Investing Activities (MM)	Cash From Financing Activities (MM)
2023-12-31	-57.24	28.84	-1.14
2023-09-30	-59.87	56.46	-0.94
2023-06-30	-58.09	-17.79	-0.64
2023-03-31	-56.47	-44.94	-0.76
2022-12-31	-55.93	-54.39	-0.17
2022-09-30	-55.41	-82.87	70.80
2022-06-30	-65.10	-2.57	70.54
2022-03-31	-72.26	-2.03	149.90
2021-12-31	-80.99	-1.32	196.17
2021-09-30	-78.27	-0.50	150.04
2021-06-30	-70.58	-0.51	168.57
2021-03-31	-59.91	-1.48	105.89
2020-12-31	-33.91	-1.48	66.11

Valuation Metrics : PE, PriceToBook, PriceToTBV

The p/e for Vaxxinity, Inc. as of December 31, 2023 is -1.63.
The p/book for Vaxxinity, Inc. as of December 31, 2023 is 4.54.
The p/tbv for Vaxxinity, Inc. as of December 31, 2023 is 4.54.

P/Book: The current closing price divided by the book value per share.

P/TBV: The current price divided by the tangible book value per share.

Period End (TTM)	p/e	P/Book	P/TBV
2023-12-31	-1.63	4.54	4.54
2023-09-30	-2.43	5.00	5.00
2023-06-30	-4.48	7.32	7.32
2023-03-31	-3.84	4.64
2022-12-31		2.20	2.20
2022-09-30		2.23	2.23
2022-06-30	-1.59	1.74	1.74
2022-03-31	-3.90	4.16	4.16
2021-12-31	-6.95	7.55	8.79
2021-09-30
2021-06-30
2021-03-31
2020-12-31

Valuation Metrics : EBitToEv, EBit3YrAvgToEv

The ebit/ev for Vaxxinity, Inc. as of December 31, 2023 is -0.64.
The ebit (3y)/ev for Vaxxinity, Inc. as of December 31, 2023 is -0.87.

Period End (TTM)	EBIT/EV	EBIT (3y)/EV
2023-12-31	-0.64	-0.87
2023-09-30	-0.48	-0.60
2023-06-30	-0.23	-0.29
2023-03-31	-0.28	-0.33
2022-12-31	-0.61	-0.41
2022-09-30	-0.90	-0.55
2022-06-30	-1.50	-0.91
2022-03-31	-0.34	-0.18
2021-12-31	-0.12	-0.06
2021-09-30
2021-06-30
2021-03-31
2020-12-31

Management Effectiveness

The roa for Vaxxinity, Inc. as of December 31, 2023 is -0.54.
The roe for Vaxxinity, Inc. as of December 31, 2023 is -0.82.
The roic for Vaxxinity, Inc. as of December 31, 2023 is -1.78.
The croic for Vaxxinity, Inc. as of December 31, 2023 is -0.12.
The ocroic for Vaxxinity, Inc. as of December 31, 2023 is -1.62.

Period End (TTM)	ROA	ROE	ROIC	CROIC	OCROIC
2023-12-31	-0.54	-0.82	-1.78	-0.12	-1.62
2023-09-30	-0.49	-0.64	-1.48	-1.57	-1.19
2023-06-30	-0.51	-0.67	-1.43	-1.52	-1.15
2023-03-31	-0.51	-0.67	-1.24	-1.68	-0.93
2022-12-31	-0.76	-1.10	-1.13	-0.74	-0.61
2022-09-30	-0.91	-1.32	-1.13	-0.74	-0.61
2022-06-30	-0.87	-1.13	-0.92	0.02	-0.53
2022-03-31	-1.68	-2.45	-1.00	0.61	-0.59
2021-12-31	-2.03		-0.98	0.82	-0.75
2021-09-30			-0.97	0.68	-0.75
2021-06-30	-55.03		-0.73	0.81	-0.59
2021-03-31	-41.66		-0.99	0.66	-0.89
2020-12-31	-25.05		-2.98	2.29	-2.53

Gross Margins

Gross Margin: The Gross Margin is the ratio of revenue left after substracting the Cost of Goods Sold. It is calculated as 1.0 - (Revenue - COGS ) / Revenue.

Net Margin: The Net Margin (aka Profit Margin) is the ratio of revenue left after substracting the Net Income. It is calculated as Net Income / Revenue.

Operating Margin: The Operaing Margin is the ratio of revenue left after substracting the Operating Income. It is calculated as Operating Income / Revenue.

Period End (TTM)	Gross Margin	Net Margin	Operating Margin
2023-12-31
2023-09-30
2023-06-30
2023-03-31
2022-12-31	1.00	102,621.00	102,906.00
2022-09-30	-38.51	102,621.00	102,906.00
2022-06-30	-38.51	-2,321.61	-2,314.53
2022-03-31	-28.35	-2,518.71	-2,509.86
2021-12-31	-27.91	-2,078.41	-1,895.08
2021-09-30	-27.91	-1,517.96	-1,320.09
2021-06-30	-12.07	-655.05	-528.84
2021-03-31	0.91	-115.75	-84.32
2020-12-31	0.91	-71.74	-57.96